WASHINGTON — A young woman whose father founded a biotechnology company in pursuit of a treatment for her rare disease will be front and center on Tuesday night for President Trump’s address to a joint session of Congress.

Megan Crowley, a college student who was diagnosed with Pompe disease at 15 months old, will be seated alongside first lady Melania Trump during the address. Beforehand, Crowley and her father, John, will meet with Trump in the Oval Office to discuss rare disease treatments.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • My daughter is 5 and was diagnosed with Pompe at 3 months old! It’s been such a long journey and we are struggling with finances and depression and I was wondering if anyone would be interested in helping our family towards our gofundme campaign? I’ve tried so many other avenues but they’ve all lead to nothing.

  • Very interesting! I recently did an article on how telemedicine can be used to reach remote patients. This story is very interesting as it relates to a few of the trends that we are seeing in the healthcare arena; there will be some major changes to the industry over the next few years.

  • I recently met Katie Meyler after her presentation at Amicus Therapeutics. She is the founder of More Than Me, a nonprofit organization that provides girls with the education, health and social services they need in the Ebola stricken slum of West Point, Liberia. During her caregiver role in the fight against Ebola Katie realized that you cannot wait for medical agencies, governments or aid organizations to come in and “be the hero”. The problem was overwhelming. She needed to “be the hero”. I believe that John Crowley and Megan have received the same revelation and are acting upon it. If only we all would do the same…

  • Has the this drug been use as an experiment for Duchesne’s Muscular Dystrophy. You mentioned muscle damage so that’s why i’m asking. Thank you for time.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy